Pier Capital LLC lifted its holdings in shares of Ardent Health, Inc. (NYSE:ARDT – Free Report) by 33.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 580,620 shares of the company’s stock after buying an additional 145,703 shares during the period. Ardent Health makes up 1.2% of Pier Capital LLC’s portfolio, making the stock its 26th biggest position. Pier Capital LLC’s holdings in Ardent Health were worth $7,693,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of the business. KLP Kapitalforvaltning AS bought a new position in Ardent Health during the 3rd quarter valued at about $80,000. New York State Common Retirement Fund grew its stake in shares of Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after acquiring an additional 3,400 shares during the period. State of Alaska Department of Revenue bought a new stake in shares of Ardent Health in the third quarter worth approximately $103,000. Marshall Wace LLP purchased a new position in shares of Ardent Health during the second quarter valued at approximately $147,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in shares of Ardent Health during the third quarter valued at approximately $155,000.
Ardent Health Price Performance
Shares of NYSE:ARDT opened at $9.20 on Friday. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $1.32 billion, a PE ratio of 9.58 and a beta of 0.46. The firm’s 50 day moving average price is $9.01 and its 200-day moving average price is $10.89. Ardent Health, Inc. has a twelve month low of $8.07 and a twelve month high of $15.48.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Royal Bank Of Canada dropped their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday. Morgan Stanley reiterated an “equal weight” rating and set a $12.00 target price (down from $22.00) on shares of Ardent Health in a research note on Friday, November 14th. Truist Financial lowered their price target on Ardent Health from $21.00 to $13.00 and set a “buy” rating on the stock in a report on Friday, November 14th. KeyCorp downgraded Ardent Health from an “overweight” rating to a “sector weight” rating in a research note on Monday, November 17th. Finally, Stephens cut their price objective on Ardent Health from $21.00 to $17.00 and set an “overweight” rating for the company in a report on Friday, November 14th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $14.25.
Check Out Our Latest Stock Report on ARDT
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
See Also
- Five stocks we like better than Ardent Health
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health, Inc. (NYSE:ARDT – Free Report).
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
